Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Pilot

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
The Journal of Biological Chemistry|January 5, 1988
cDNA, deduced polypeptide structure and chromosomal assignment of human pulmonary surfactant proteolipid, SPL(pVal)S W Glasser, T R Korfhagen, T E Weaver, et al.
International Dental Journal|August 1, 1996
The community care model of the Intercountry Centre for Oral Health at Chiangmai, ThailandT Anumanrajadhon, S Rajchagool, P Nitisiri, et al.
Journal of Viral Hepatitis|April 7, 2018
Characterization of demographics and NS5A genetic diversity for hepatitis C virus genotype 4-infected patients with or without cirrhosis treated with ombitasvir/paritaprevir/ritonavirG Schnell, R Tripathi, J Beyer, et al.
Journal of Viral Hepatitis|August 24, 2017
Efficacy and safety results of patients with HCV genotype 2 or 3 infection treated with ombitasvir/paritaprevir/ritonavir and sofosbuvir with or without ribavirin (QUARTZ II-III)S D Shafran, D Shaw, M Charafeddine, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
The Journal of Biological Chemistry|January 5, 1988
cDNA, deduced polypeptide structure and chromosomal assignment of human pulmonary surfactant proteolipid, SPL(pVal)S W Glasser, T R Korfhagen, T E Weaver, et al.
International Dental Journal|August 1, 1996
The community care model of the Intercountry Centre for Oral Health at Chiangmai, ThailandT Anumanrajadhon, S Rajchagool, P Nitisiri, et al.
Journal of Viral Hepatitis|April 7, 2018
Characterization of demographics and NS5A genetic diversity for hepatitis C virus genotype 4-infected patients with or without cirrhosis treated with ombitasvir/paritaprevir/ritonavirG Schnell, R Tripathi, J Beyer, et al.
Journal of Viral Hepatitis|August 24, 2017
Efficacy and safety results of patients with HCV genotype 2 or 3 infection treated with ombitasvir/paritaprevir/ritonavir and sofosbuvir with or without ribavirin (QUARTZ II-III)S D Shafran, D Shaw, M Charafeddine, et al.
Pageof 4